These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37559053)

  • 1. Molecular mechanisms and treatment responses of pulmonary fibrosis in severe COVID-19.
    Kooistra EJ; Dahm K; van Herwaarden AE; Gerretsen J; Nuesch Germano M; Mauer K; Smeets RL; van der Velde S; van den Berg MJW; van der Hoeven JG; Aschenbrenner AC; Schultze JL; Ulas T; Kox M; Pickkers P
    Respir Res; 2023 Aug; 24(1):196. PubMed ID: 37559053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between methylprednisolone infusion and dexamethasone in COVID-19 ARDS mechanically ventilated patients.
    Saeed MAM; Mohamed AH; Owaynat AH
    Egypt J Intern Med; 2022; 34(1):19. PubMed ID: 35194371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of dexamethasone on the incidence of ventilator-associated pneumonia in mechanically ventilated COVID-19 patients: a propensity-matched cohort study.
    Scaravilli V; Guzzardella A; Madotto F; Beltrama V; Muscatello A; Bellani G; Monti G; Greco M; Pesenti A; Bandera A; Grasselli G
    Crit Care; 2022 Jun; 26(1):176. PubMed ID: 35698155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.
    Maláska J; Stašek J; Duška F; Balík M; Máca J; Hruda J; Vymazal T; Klementová O; Zatloukal J; Gabrhelík T; Novotný P; Demlová R; Kubátová J; Vinklerová J; Svobodník A; Kratochvíl M; Klučka J; Gál R; Singer M;
    Trials; 2021 Mar; 22(1):172. PubMed ID: 33648568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remdesivir plus Dexamethasone in COVID-19: A cohort study of severe patients requiring high flow oxygen therapy or non-invasive ventilation.
    De Pascale G; Cutuli SL; Carelli S; Xhemalaj R; Rosà T; Bello G; Vargas J; Cesarano M; Montini L; Tanzarella ES; Pintaudi G; Di Muro M; Grieco DL; Antonelli M
    PLoS One; 2022; 17(4):e0267038. PubMed ID: 35482703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with critical care requirements in diabetic patients treated with dexamethasone for COVID-19 infection in the first wave of the pandemia.
    Batule S; Soldevila B; Figueredo C; Julián MT; Egea-Cortés L; Reyes-Ureña J; Casabona J; Mateu L; Paredes R; Clotet B; López R; Puig-Domingo M; Alonso N
    Front Endocrinol (Lausanne); 2022; 13():1009028. PubMed ID: 36619546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
    Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
    Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review.
    Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexamethasone vs methylprednisolone high dose for Covid-19 pneumonia.
    Pinzón MA; Ortiz S; Holguín H; Betancur JF; Cardona Arango D; Laniado H; Arias Arias C; Muñoz B; Quiceno J; Jaramillo D; Ramirez Z
    PLoS One; 2021; 16(5):e0252057. PubMed ID: 34033648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectivity of mesenchymal stem cells for bleomycin-induced pulmonary fibrosis: a systematic review and implication for clinical application.
    Zhao Y; Yan Z; Liu Y; Zhang Y; Shi J; Li J; Ji F
    Stem Cell Res Ther; 2021 Aug; 12(1):470. PubMed ID: 34420515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dimensional comparison of monocytes and T cells in post-COVID and idiopathic pulmonary fibrosis.
    Bingham GC; Muehling LM; Li C; Huang Y; Ma SF; Abebayehu D; Noth I; Sun J; Woodfolk JA; Barker TH; Bonham CA
    Front Immunol; 2023; 14():1308594. PubMed ID: 38292490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outpatient treatment of COVID-19 with steroids in the phase of mild pneumonia without the need for admission as an opportunity to modify the course of the disease: A structured summary of a randomised controlled trial.
    Saiz-Rodríguez M; Peña T; Lázaro L; González Á; Martínez A; Cordero JA; Vicente JT; Richard F; Coma MJ; de Frutos M; Labrador J; Pueyo A
    Trials; 2020 Jul; 21(1):632. PubMed ID: 32646502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive care for seriously ill patients affected by novel coronavirus sars - CoV - 2: Experience of the Crema Hospital, Italy.
    Zuccon W; Comassi P; Adriani L; Bergamaschini G; Bertin E; Borromeo R; Corti S; De Petri F; Dolci F; Galmozzi A; Gigliotti A; Gualdoni L; Guerra C; Khosthiova A; Leati G; Lupi G; Moscato P; Perotti V; Piantelli M; Ruini A; Sportelli S; Susca M; Troiano C; Benelli G; Buscarini E; Canetta C; Merli G; Scartabellati A; Melilli B S C G; Sfogliarini R; Pellegatta G; Viganò G
    Am J Emerg Med; 2021 Jul; 45():156-161. PubMed ID: 33046317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
    Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
    JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of dexamethasone on the incidence of ventilator-associated pneumonia and blood stream infections in COVID-19 patients requiring invasive mechanical ventilation: a multicenter retrospective study.
    Gragueb-Chatti I; Lopez A; Hamidi D; Guervilly C; Loundou A; Daviet F; Cassir N; Papazian L; Forel JM; Leone M; Dellamonica J; Hraiech S
    Ann Intensive Care; 2021 May; 11(1):87. PubMed ID: 34057642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive ventilation in the event of acute respiratory failure in patients with idiopathic pulmonary fibrosis.
    Vianello A; Arcaro G; Battistella L; Pipitone E; Vio S; Concas A; Paladini L; Gallan F; Marchi MR; Tona F; Iliceto S
    J Crit Care; 2014 Aug; 29(4):562-7. PubMed ID: 24768565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.
    Naqvi SF; Lakhani DA; Sohail AH; Maurer J; Sofka S; Sarwari A; Hadi YB
    BMJ Open Respir Res; 2021 Aug; 8(1):. PubMed ID: 34376400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.